Financial News
Biotech ETFs Strengthen as Amgen Invests in China’s BeiGene
November 01, 2019 at 15:18 PM EDT
Biotechnology company Amgen (NasdaqGS: AMGN) is throwing $2.7 billion into BeiGene (NasdaqGS: BGNE), sending the Chinese biotech’s shares surging and bolstering sector-related ETFs. Among the top performers on Friday, the Loncar Cancer Immunotheraphy ETF (NasdaqGM: CNCR) increased 3.2% and...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
